Skip to content

Clinical trials

Phase 1/2 Mucopolysaccharidosis III trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Phase: Phase 1/2 Country / region: Spain Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abeona Therapeutics, Inc1
Alexion Pharmaceuticals, Inc.1
Allievex Corporation1
Ultragenyx Pharmaceutical Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III4
Carbohydrate Metabolism, Inborn Errors1
Connective Tissue Diseases1
Genetic Diseases, Inborn1
Lysosomal Storage Diseases1
Metabolic Diseases1
Metabolism, Inborn Errors1
Mucinoses1
Mucopolysaccharidoses1
Pathologic Processes1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.